Right now this market is jumping up and down and screaming at anything involving outpatient healthcare. One miss by a big company and boom goes the dynamite. While you may be hurting today if you were a shareholder heading into the news, it’s a great opportunity for anybody in cash, on the sidelines looking in.

I’ve put together a quick list of the highest rated stocks in this industry. These are Zacks Rank #1 (Strong Buy) and Zacks Rank #2 (Buy) stocks that are in an industry we have in the Top 7% of our Zacks Industry Rank. The downside pressure may be presenting us with a fantastic buying opportunity. Are we really going to let one company give a black eye to an entire industry?

While I’m not going to speculate on the impact around the rest of the industry, I am going to look for stocks that are probably a bit overdone on this selling today. Especially when the rest of the market is performing so well. Can you imagine how much the Nasdsaq (QQQ) would be up if these stocks were a participant in the rally?

AmSurg (AMSG – Analyst Report)

AmSurg Corp., through its subsidiaries, provides ambulatory and physician services in the United States. The company operates through two divisions, Ambulatory Services and Physician Services. The Ambulatory Services division acquires, develops, and operates ambulatory surgery centers (ASCs) in partnership with physicians. The Physician Services division provides outsourced physician services to hospitals, ASCs, and other healthcare facilities primarily in the areas of anesthesiology services; children’s services, such as neonatal management services specializing in acute inpatient care and treatment of infants; emergency medicine services; and radiology services, including diagnostic, and interventional and tele radiology services to hospitals, imaging centers, and physician group practices, as well as other services.

AMSG probably has experienced the worst drop of all these stocks. The dip started near $85 a couple of weeks ago. Shares came down to support at $75 but a couple of rough days for the industry have sparked a selloff even further. Now trading intraday all the way down to the $60 level, this could be a great buying opportunity.